Pregnancies in women with Turner syndrome: a retrospective multicentre UK study.


Journal

BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741

Informations de publication

Date de publication:
Apr 2022
Historique:
accepted: 16 11 2021
pubmed: 21 11 2021
medline: 5 4 2022
entrez: 20 11 2021
Statut: ppublish

Résumé

To determine the characteristics and outcomes of pregnancy in women with Turner syndrome. Retrospective 20-year cohort study (2000-20). Sixteen tertiary referral maternity units in the UK. A total of 81 women with Turner syndrome who became pregnant. Retrospective chart analysis. Mode of conception, pregnancy outcomes. We obtained data on 127 pregnancies in 81 women with a Turner phenotype. All non-spontaneous pregnancies (54/127; 42.5%) were by egg donation. Only 9/31 (29%) pregnancies in women with karyotype 45,X were spontaneous, compared with 53/66 (80.3%) pregnancies in women with mosaic karyotype 45,X/46,XX (P < 0.0001). Women with mosaic karyotype 45,X/46,XX were younger at first pregnancy by 5.5-8.5 years compared with other Turner syndrome karyotype groups (P < 0.001), and more likely to have a spontaneous menarche (75.8% versus 50% or less, P = 0.008). There were 17 miscarriages, three terminations of pregnancy, two stillbirths and 105 live births. Two women had aortic dissection (2.5%); both were 45,X karyotype with bicuspid aortic valves and ovum donation pregnancies, one died. Another woman had an aortic root replacement within 6 months of delivery. Ten of 106 (9.4%) births with gestational age data were preterm and 22/96 (22.9%) singleton infants with birthweight/gestational age data weighed less than the tenth centile. The caesarean section rate was 72/107 (67.3%). In only 73/127 (57.4%) pregnancies was there documentation of cardiovascular imaging within the 24 months before conceiving. Pregnancy in women with Turner syndrome is associated with major maternal cardiovascular risks; these women deserve thorough cardiovascular assessment and counselling before assisted or spontaneous pregnancy managed by a specialist team. Pregnancy in women with Turner syndrome is associated with an increased risk of aortic dissection.

Identifiants

pubmed: 34800331
doi: 10.1111/1471-0528.17025
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

796-803

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2021 John Wiley & Sons Ltd.

Références

Miyabara S, Nakayama M, Suzumori K, Yonemitsu N, Sugihara H. Developmental analysis of cardiovascular system of 45, X fetuses with cystic hygroma. Am J Med Genet 1997;68:135-41.
Gravholt CH, Andersen NH, Conway GS, Dekkers OM, Geffner ME, Klein KO, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol 2017;177:G1-70.
Surerus E, Huggon IC, Allan LD. Turner's syndrome in fetal life. Ultrasound Obstet Gynecol 2003;22:264-7.
Ho VB, Bakalov VK, Cooley M, Van PL, Hood MN, Burklow TR, et al. Major vascular anomalies in Turner syndrome: prevalence and magnetic resonance angiographic features. Circulation 2004;110:1694-700.
Bondy CA. Aortic dissection in Turner syndrome. Curr Opin Cardiol 2008;23:519-26.
De Groote K, Demulier L, De Backer J, De Wolf D, De Schepper J, T'sjoen G, et al. Arterial hypertension in Turner syndrome: a review of the literature and a practical approach for diagnosis and treatment. J Hypertens 2015;33:1342-51.
Thunström S, Krantz E, Thunström E, Hanson C, Bryman I, Landin-Wilhelmsen K. Incidence of aortic dissection in turner syndrome. Circulation 2019;139:2802-4.
Pasquino AM, Passeri F, Pucarelli I, Segni M, Municchi G. Spontaneous pubertal development in Turner's syndrome. Italian Study Group for Turner's Syndrome. J Clin Endocrinol Metab 1997;82:1810-3.
Hovatta O. Pregnancies in women with Turner's syndrome. Ann Med 1999;31:106-10.
Bernard V, Donadille B, Zenaty D, Courtillot C, Salenave S, Brac de la Perrière A, et al. Spontaneous fertility and pregnancy outcomes amongst 480 women with Turner syndrome. Hum Reprod 2016;31:782-8.
Bryman I, Sylvén L, Berntorp K, Innala E, Bergström I, Hanson C, et al. Pregnancy rate and outcome in Swedish women with Turner syndrome. Fertil Steril 2011;95:2507-10.
Calanchini M, Aye CYL, Orchard E, Baker K, Child T, Fabbri A, et al. Fertility issues and pregnancy outcomes in Turner syndrome. Fertil Steril 2020;114:144-54.
Andre H, Pimentel C, Veau S, Domin-Bernhard M, Letur-Konirsch H, Priou G, et al. Pregnancies and obstetrical prognosis after oocyte donation in Turner Syndrome: a multicentric study. Eur J Obstet Gynecol Reprod Biol 2019;238:73-7.
Hagman A, Loft A, Wennerholm UB, Pinborg A, Bergh C, Aittomäki K, et al. Obstetric and neonatal outcome after oocyte donation in 106 women with Turner syndrome: a Nordic cohort study. Hum Reprod 2013;28:1598-609.
Alvaro Mercadal B, Imbert R, Demeestere I, Englert Y, Delbaere A. Pregnancy outcome after oocyte donation in patients with Turner's syndrome and partial X monosomy. Hum Reprod 2011;26:2061-8.
Chevalier N, Letur H, Lelannou D, Ohl J, Cornet D, Chalas-Boissonnas C, et al. Materno-fetal cardiovascular complications in Turner syndrome after oocyte donation: insufficient prepregnancy screening and pregnancy follow-up are associated with poor outcome. J Clin Endocrinol Metab 2011;96:E260-7.
Grewal J, Valente AM, Egbe AC, Wu FM, Krieger EV, Sybert VP, et al. Cardiovascular outcomes of pregnancy in Turner syndrome. Heart 2021;107:61-6.
Silberbach M, Roos-Hesselink JW, Andersen NH, Braverman AC, Brown N, Collins RT, et al. Cardiovascular health in Turner Syndrome: a scientific statement from the American Heart Association. Circ Genom Precis Med. 2018;11:e000048.
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstrom-Lundqvist C, Cifkova R, De Bonis M, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018;39:3165-241.
Braunthal S, Brateanu A. Hypertension in pregnancy: Pathophysiology and treatment. SAGE Open Med 2019;7:2050312119843700.
Mortensen KH, Young L, De Backer J, Silberbach M, Collins RT, Duijnhouwer AL, et al. Cardiovascular imaging in Turner syndrome: state-of-the-art practice across the lifespan. Heart 2018;104:1823-31.
Cadoret F, Parinaud J, Bettiol C, Pienkowski C, Letur H, Ohl J, et al. Pregnancy outcome in Turner syndrome: a French multi-center study after the 2009 guidelines. Eur J Obstet Gynecol Reprod Biol 2018;229:20-5.
Ramage K, Grabowska K, Silversides C, Quan H, Metcalfe A. Maternal, pregnancy, and neonatal outcomes for women with Turner syndrome. Birth Defects Res 2020;112:1067-73.
Farrar D, Simmonds M, Griffin S, Duarte A, Lawlor DA, Sculpher M, et al. The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation. Health Technol Assess 2016;20:1-348.
Stacey T, Tennant P, McCowan L, Mitchell EA, Budd J, Li M, et al. Gestational diabetes and the risk of late stillbirth: a case-control study from England, UK. BJOG 2019;126:973-82.
Söderström-Anttila V, Pinborg A, Karnis MF, Reindollar RH, Paulson RJ. Should women with Turner syndrome be allowed to carry their own pregnancies? Fertil Steril 2019;112:220-5.
Cauldwell M, Steer PJ, Curtis SL, Mohan A, Dockree S, Mackillop L, et al. Maternal and fetal outcomes in pregnancies complicated by Marfan syndrome. Heart 2019;105:1725-31.

Auteurs

M Cauldwell (M)

Department of Obstetrics, Maternal Medicine Service, St George's Hospital, London, UK.

P J Steer (PJ)

Academic Department of Obstetrics and Gynaecology, Chelsea and Westminster Hospital, London, UK.

D Adamson (D)

Department of Cardiology, University Hospitals Coventry and Warwickshire, Coventry, UK.

C Alexander (C)

Department of Obstetrics, Edinburgh Royal Infirmary, Edinburgh, UK.

L Allen (L)

Department of Endocrinology, Cardiff and Vale University Health Board, Cardiff, UK.

C Bhagra (C)

Department of Cardiology, Addenbrookes Hospital, Cambridge, UK.

A Bolger (A)

Department of Adult Congenital Heart Disease, Glenfield Hospital, Leicester, UK.

S Bonner (S)

Saint Mary's Managed Clinical Service, Manchester University Foundation Trust, Manchester, UK.

M Calanchini (M)

Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

A Carroll (A)

Department of Congenital Cardiology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

R Casey (R)

Department of Endocrinology, Addenbrookes Hospital, Cambridge, UK.

S Curtis (S)

Adult Congenital Heart Disease Service, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.

C Head (C)

Cardiology Department, Norfolk and Norwich University Hospital, Norwich, UK.

K English (K)

Department of Adult Congenital Heart Disease, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

L Hudsmith (L)

Department of Adult Congenital Heart Disease, University Hospitals Birmingham, Birmingham, UK.

R James (R)

Department of Cardiology, University Hospitals Sussex, Brighton, UK.

E Joy (E)

Department of Adult Congenital Heart Disease, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

N Keating (N)

Department of Obstetrics, UCD Perinatal Research Centre, School of Medicine, University College Dublin, National Maternity Hospital, Dublin, Ireland.

L MacKiliop (L)

Women's Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

F McAuliffe (F)

Department of Obstetrics, UCD Perinatal Research Centre, School of Medicine, University College Dublin, National Maternity Hospital, Dublin, Ireland.

R K Morris (RK)

Academic Department of Obstetrics, Birmingham Women's and Children's NHS Foundation Trust, University of Birmingham, Birmingham, UK.

A Mohan (A)

Department of Obstetrics, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.

K Von Klemperer (K)

Adult Congenital Heart Disease, Barts Heart Centre, London, UK.

M Kaler (M)

Department of Obstetrics, Royal London Hospital, London, UK.

D A Rees (DA)

Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, UK.

A Shetty (A)

Department of Obstetrics, Aberdeen Royal Infirmary, Aberdeen, UK.

F Siddiqui (F)

Department of Obstetrics, Royal Leicester Infirmary, Leicester, UK.

L Simpson (L)

Department of Obstetrics, Edinburgh Royal Infirmary, Edinburgh, UK.

L Stocker (L)

Department of Obstetrics, Princess Anne Hospital, Southampton, UK.

P Timmons (P)

Department of Obstetrics, Norfolk and Norwich University Hospitals, Norwich, UK.

S Vause (S)

Saint Mary's Managed Clinical Service, Manchester University Foundation Trust, Manchester, UK.

H E Turner (HE)

Department of Endocrinology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH